Vimarsana
Biggest News Aggregation in the World

Page 2 - Daniel Ferry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Ferry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Ferry Today - Breaking & Trending Today

CRYSTAL CLINIC ORTHOPAEDIC CENTER EXPANDS TO ASHTABULA - Vimarsana News

CRYSTAL CLINIC ORTHOPAEDIC CENTER EXPANDS TO ASHTABULA

/PRNewswire/ -- Crystal Clinic Orthopaedic Center's regional expansion continues as the physician-owned hospital system, dedicated exclusively to orthopaedics...

BioAge Hosting Webcast to Discuss Newly Announced Phase 1b Data Demonstrating BGE-105 Significantly - Vimarsana News

BioAge Hosting Webcast to Discuss Newly Announced Phase 1b Data Demonstrating BGE-105 Significantly

Experts and company leadership to discuss clinical significance of indications driven by muscle atrophy and Ph2 trial design for acute ICU myopathies in older patientsRICHMOND, Calif.--(BUSINESS WIRE)--#aging--BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target th...

CorMedix Inc Common Stock (CRMD) Q3 2022 Earnings Call Transcript - Vimarsana News

CorMedix Inc Common Stock (CRMD) Q3 2022 Earnings Call Transcript

CRMD earnings call for the period ending September 30, 2022.

Source: fool.com
Man pays €10k compo after breaking into ex's flat and battering new boyfriend in jealous rage - Vimarsana News

Man pays €10k compo after breaking into ex's flat and battering new boyfriend in jealous rage

A man who broke into his ex-girlfriend's flat and battered her new boyfriend as the couple slept has avoided jail after paying his victims €10,000.

BioAge Labs to Present Data on Novel Brain-Penetrant NLRP3 Inhibitors for Treatment of Neurodegenera - Vimarsana News

BioAge Labs to Present Data on Novel Brain-Penetrant NLRP3 Inhibitors for Treatment of Neurodegenera

Family of NLRP3 inhibitors is differentiated by novel structure, central nervous system penetration, and potential for improved safety and efficacyRICHMOND, Calif.--(BUSINESS WIRE)--#aging--BioAge Labs, Inc. (“BioAge”), a privately held clinical-stage biotechnology company developing therapeutics that target the mol...